CISPLATINUM AS A SINGLE AGENT VERSUS CISPLATINUM IN 2 DRUG-COMBINATION IN ADVANCED AND RECURRENT HEAD AND NECK-CANCER

被引：0
|
作者：
CAMPBELL, JB
MORTON, RP
DORMAN, EB
RUGMAN, F
WILSON, JA
STELL, PM
机构：
来源：
CLINICAL OTOLARYNGOLOGY | 1987年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [31] CISPLATINUM AND BLEOMYCIN FOR ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A RANDOMIZED FACTORIAL PHASE-III CONTROLLED TRIAL
    MORTON, RP
    RUGMAN, F
    DORMAN, EB
    STONEY, PJ
    WILSON, JA
    MCCORMICK, M
    VEEVERS, A
    STELL, PM
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (03) : 283 - 289
  • [32] A comparative study of the response and toxicities in locally advanced head and neck cancer patients treated with paclitaxel, cisplatinum, 5-FU versus docetaxel, cisplatinum, 5-FU as neoadjuvant chemotherapy followed by concurrent chemoradiation.
    Samanta, Diptirani
    Senapati, Surendra Nath
    Mohanty, Kirti Ranjan
    Das, Saroj
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors
    Kuhnt, Thomas
    Becker, Axel
    Bloching, Marc
    Schubert, Johannes
    Klautke, Gunther
    Fietkau, Rainer
    Dunst, Juergen
    MEDICAL ONCOLOGY, 2006, 23 (03) : 325 - 333
  • [34] Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors
    Thomas Kuhnt
    Axel Becker
    Marc Bloching
    Johannes Schubert
    Gunther Klautke
    Rainer Fietkau
    Juergen Dunst
    Medical Oncology, 2006, 23 : 325 - 333
  • [35] SYNCHRONOUS RADIOTHERAPY AND CHEMOTHERAPY WITH CISPLATIN IN THE MANAGEMENT OF LOCALLY ADVANCED OR RECURRENT HEAD AND NECK-CANCER
    GASPARINI, G
    RECHER, GF
    TESTOLIN, A
    DALFIOR, S
    PANIZZONI, GA
    CRISTOFERI, V
    SQUAQUARA, R
    POZZA, F
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (03): : 242 - 249
  • [36] SHORT COURSE HIGH FRACTIONAL DOSE IRRADIATION IN ADVANCED AND RECURRENT HEAD AND NECK-CANCER
    LEE, DJ
    WHARAM, MD
    KASHIMA, H
    ORDER, SE
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1979, 5 (10): : 1829 - 1832
  • [37] A PRELIMINARY-REPORT ON THE COMBINATION OF INITIAL CHEMOTHERAPY AND RADIOTHERAPY FOR ADVANCED HEAD AND NECK-CANCER
    SERGEANT, R
    DEUTSCH, G
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1981, 95 (01): : 69 - 73
  • [38] COMBINATION CHEMOTHERAPY WITH BLEOMYCIN (BLEO) AND HYDROXYUREA (HU) IN THE TREATMENT OF ADVANCED HEAD AND NECK-CANCER
    EISENBERGER, M
    DENEFRIO, JM
    KAPLAN, DL
    SILVERMAN, M
    LESSNER, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 343 - 343
  • [39] PREOPERATIVE COMBINATION CHEMOTHERAPY FOR ADVANCED STAGE HEAD AND NECK-CANCER - PROMISING EARLY RESULTS
    KIES, MS
    PECARO, BC
    GORDON, LI
    HAUCK, WW
    KRAUT, MJ
    KRESPI, Y
    OSSOFF, RH
    SCHIFF, C
    SHETTY, R
    SISSON, GA
    AMERICAN JOURNAL OF SURGERY, 1984, 148 (03): : 367 - 371
  • [40] SINGLE-AGENT PACLITAXEL AND PACLITAXEL PLUS IFOSFAMIDE IN THE TREATMENT OF HEAD AND NECK-CANCER
    FORASTIERE, AA
    URBA, SG
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 24 - 27
12345